UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049822
Receipt number R000056741
Scientific Title Intermediate distance visual acuity in the Clareon monofocal intraocular lenses
Date of disclosure of the study information 2022/12/19
Last modified on 2022/12/19 11:06:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Intermediate distance visual acuity in the Clareon monofocal intraocular lenses

Acronym

Intermediate distance visual acuity in the Clareon monofocal intraocular lenses

Scientific Title

Intermediate distance visual acuity in the Clareon monofocal intraocular lenses

Scientific Title:Acronym

Intermediate distance visual acuity in the Clareon monofocal intraocular lenses

Region

Japan


Condition

Condition

pseudophakia

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate visual function at 3 months postoperatively for Clareon /Clareon Toric

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Binocular best corrected distance visual acuity at 3 months after surgery

Key secondary outcomes

1.Binocular naked eye far visual acuity at 3 months after surgery
2.Binocular far-corrected intermediate visual acuity ( 80cm, 66cm) at 3 months after surgery
3.Binocular naked eye intermediate visual acuity ( 80cm, 66cm) at 3 months after surgery
4.Best corrected far visual acuity in one eye 3 months after surgery
5.Naked eye far visual acuity of one eye at 3 months after surgery
6.Postoperative intermediate distance-corrected visual acuity of one eye at 3 months ( 80cm, 66cm)
7.Naked eye intermediate visual acuity of one eye at 3 months after surgery ( 80cm, 66cm)
8.Defocused curves 3 months after surgery
9.Postoperative refractive error
10.Distribution of visual acuity


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Binocular age-related cataract patients
2.Men and women over 20 years old
3.Patients scheduled for bilateral Clareon or Clareon Toric insertions with positive vision in both eyes
4.Patients can expect postoperative distance-corrected visual acuity of 0.7 or better in one eye

Key exclusion criteria

1.Patients with ocular diseases affecting visual function other than cataract
2.Patients with corneal irregular astigmatism
3.Glaucoma patients
4.Patients with a history of corneal refractive surgery, endophthalmic surgery, and keratoplasty
5.Patients deemed inappropriate by the responsible physician or subspecialist due to systemic or ophthalmologic diseases

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Iichiro
Middle name
Last name Sugita

Organization

Medical Corporation Sugita Eye Hospital

Division name

Ophthalmology

Zip code

460-0008

Address

5-1-30 Sakae, Naka-ku, Nagoya City, Aichi

TEL

052-251-6571

Email

iichiro@sugita.or.jp


Public contact

Name of contact person

1st name Iichiro
Middle name
Last name Sugita

Organization

Medical Corporation Sugita Eye Hospital

Division name

Ophthalmology

Zip code

460-0008

Address

5-1-30 Sakae, Naka-ku, Nagoya City, Aichi

TEL

052-251-6571

Homepage URL


Email

iichiro@sugita.or.jp


Sponsor or person

Institute

Medical Corporation Sugita Eye Hospital

Institute

Department

Personal name



Funding Source

Organization

Alcon Japan K.K.

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Corporation Sugita Eye Hospital of Medicine Ethics Committee

Address

5-1-30 Sakae, Naka-ku, Nagoya City, Aichi

Tel

052-251-6571

Email

tadasu@sugita.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 09 Month 29 Day

Date of IRB

2022 Year 10 Month 27 Day

Anticipated trial start date

2022 Year 10 Month 28 Day

Last follow-up date

2023 Year 05 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observations
1.Binocular naked eye far visual acuity at 3 months after surgery
2.Binocular far-corrected intermediate visual acuity ( 80cm, 66cm) at 3 months after surgery
3.Binocular naked eye intermediate visual acuity ( 80cm, 66cm) at 3 months after surgery
4.Best corrected far visual acuity in one eye 3 months after surgery
5.Naked eye far visual acuity of one eye at 3 months after surgery
6.Postoperative intermediate distance-corrected visual acuity of one eye at 3 months ( 80cm, 66cm)
7.Naked eye intermediate visual acuity of one eye at 3 months after surgery ( 80cm, 66cm)
8.Defocused curves 3 months after surgery
9.Postoperative refractive error
10.Distribution of visual acuity
11.Binocular best corrected distance visual acuity at 3 months after surgery


Management information

Registered date

2022 Year 12 Month 19 Day

Last modified on

2022 Year 12 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056741


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name